28 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
26824643	69	Mimicking of Arginine by Functionalized N(¿)-Carbamoylated Arginine As a New Broadly Applicable Approach to Labeled Bioactive Peptides: High Affinity Angiotensin, Neuropeptide Y, Neuropeptide FF, and Neurotensin Receptor Ligands As Examples.	University Of Regensburg
24900634	36	Design and Synthesis of Peptide YY Analogues with C-terminal Backbone Amide-to-Ester Modifications.	University Of Copenhagen
24074877	135	Dimeric argininamide-type neuropeptide Y receptor antagonists: chiral discrimination between Y1 and Y4 receptors.	University Of Regensburg
24090364	96	Replacement of Thr32 and Gln34 in the C-terminal neuropeptide Y fragment 25-36 by cis-cyclobutane and cis-cyclopentane β-amino acids shifts selectivity toward the Y(4) receptor.	University Of Regensburg
18160282	40	Discovery of novel orally active ureido NPY Y5 receptor antagonists.	Schering-Plough Research Institute
21782428	61	Discovery of Lu AA33810: a highly selective and potent NPY5 antagonist with in vivo efficacy in a model of mood disorder.	Lundbeck Research Usa
19616955	34	Discovery of pyridone-containing imidazolines as potent and selective inhibitors of neuropeptide Y Y5 receptor.	Tsukuba Research Institute
21493077	39	Red-fluorescent argininamide-type NPY Y1 receptor antagonists as pharmacological tools.	Universit£T Regensburg
19864135	43	Discovery and SAR of cyclic isothioureas as novel NPY Y1 receptor antagonists.	Schering-Plough Research Institute
20042335	12	[Lys(DOTA)4]BVD15, a novel and potent neuropeptide Y analog designed for Y1 receptor-targeted breast tumor imaging.	Universit£
19679469	26	Identification of positron emission tomography ligands for NPY Y5 receptors in the brain.	Tsukuba Research Institute
19640706	25	Synthesis and evaluation of a series of 2,4-diaminopyridine derivatives as potential positron emission tomography tracers for neuropeptide Y Y1 receptors.	Tsukuba Research Institute
19596193	72	Design, synthesis and evaluation of a novel cyclohexanamine class of neuropeptide Y Y1 receptor antagonists.	Tsukuba Research Institute
19464889	43	Aryl urea derivatives of spiropiperidines as NPY Y5 receptor antagonists.	Tsukuba Research Institute
19459652	56	Discovery of tetrasubstituted imidazolines as potent and selective neuropeptide Y Y5 receptor antagonists: reduced human ether-a-go-go related gene potassium channel binding affinity and potent antiobesity effect.	Tsukuba Research Institute
19053784	19	Guanidine-acylguanidine bioisosteric approach in the design of radioligands: synthesis of a tritium-labeled N(G)-propionylargininamide ([3H]-UR-MK114) as a highly potent and selective neuropeptide Y Y1 receptor antagonist.	University Of Regensburg
18752943	36	Syntheses and structure-activity relationships of novel, potent, and selective trans-2-[3-oxospiro[isobenzofuran-1(3H),1'-cyclohexan]-4'-yl]benzimidazole NPY Y5 receptor antagonists.	Banyu Tsukuba Research Institute
18723347	59	Design, syntheses, and structure-activity relationships of novel NPY Y5 receptor antagonists: 2-{3-Oxospiro[isobenzofuran-1(3H),4'-piperidin]-1'-yl}benzimidazole derivatives.	Banyu Tsukuba Research Institute
18637668	38	(9S)-9-(2-hydroxy-4,4-dimethyl-6-oxo-1-cyclohexen-1-yl)-3,3-dimethyl-2,3,4,9-tetrahydro-1H-xanthen-1-one, a selective and orally active neuropeptide Y Y5 receptor antagonist.	Tsukuba Research Institute
16610810	39	Neuropeptide Y (NPY) Y4 receptor selective agonists based on NPY(32-36): development of an anorectic Y4 receptor selective agonist with picomolar affinity.	University Of Cincinnati
15109631	86	Discovery and SAR of potent, orally available and brain-penetrable 5,6-dihydro-4H-3-thia-1-aza-benzo[e]azulen- and 4,5-dihydro-6-oxa-3-thia-1-aza-benzo[e]azulen derivatives as neuropeptide Y Y5 receptor antagonists.	Novartis Pharma
11334558	42	Highly selective and potent neuropeptide Y (NPY) Y1 receptor antagonists based on [Pro(30), Tyr(32), Leu(34)]NPY(28-36)-NH2 (BW1911U90).	University Of Cincinnati And Va Medical Centers
10866375	50	Design, synthesis and SAR of a series of 2-substituted 4-amino-quinazoline neuropeptide Y Y5 receptor antagonists.	Novartis Pharma
9371234	49	Potent and selective 1,2,3-trisubstituted indole NPY Y-1 antagonists.	Eli Lilly